Skip to main content
. Author manuscript; available in PMC: 2012 Mar 15.
Published in final edited form as: Anal Biochem. 2010 Nov 26;410(2):248–256. doi: 10.1016/j.ab.2010.11.034

Figure 1.

Figure 1

MALDI-TOF mass spectrum of non-glycated HSA treated with sodium borohydride (A), and of sodium borohydride reduced galactated HSA derived from incubation mixtures of non-glycated protein (240 mg) with D-galactose (1 g) in 50 mM phosphate buffer (3ml), pH 7.4 at 56ºC for 2h (B).